YTHDF2 and acute myeloid leukemia: YTHDF2 is up-regulated in AML and plays an essential role in leukemic stem cell (LSC) development and AML initiation by decreasing the half-life of tumor necrosis factor receptor TNF receptor superfamily member 2 (Tnfrsf2), which contributes to the overall integrity of LSC function.